Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Neumora Therapeutics, Inc. market cap for the quarter ending 2026-08-10 was $302.51M, a 21.30% increase year-over-year.
Neumora Therapeutics, Inc. market cap for the quarter ending 2026-05-01 was $450.24M.
Neumora Therapeutics, Inc. market cap for the quarter ending 2026-03-23 was $447.82M.
Neumora Therapeutics, Inc. market cap for the quarter ending 2025-12-31 was $311.93M.
Neumora Therapeutics, Inc. market cap for fiscal 2026 was $302.51M.
Neumora Therapeutics, Inc. market cap for fiscal 2025 was $311.93M.